Lei Yan
Impact in
-
- Ferroptosis and cancer prognosis
- Lung Cancer Treatments and Mutations
Papers in
-
- Lung Cancer Treatments and Mutations 5
- Ferroptosis and cancer prognosis 2
- Co-authors
- Jingjing Wang (1 shared paper)Xiang Shi (1 shared paper)Zhihua Zheng (8 shared papers)Kaiji Sun (1 shared paper)Guoyao Wu (1 shared paper)Zhenlong Wu (1 shared paper)Jia Hong Shi (1 shared paper)Ali Raza (2 shared papers)
- Journals
- International Immunopharmacology (2 papers)Chinese Journal of Natural Medicines (2 papers)Heliyon (2 papers)Frontiers in Immunology (2 papers)Frontiers in Plant Science (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Lei Yan
53 papers receiving 501 citations
Peers
Comparison fields: 5 of 82
- Drug Discovery 2
- Pulmonary and Respiratory Medicine 123
- Nephrology 32
- Complementary and alternative medicine 28
- Animal Science and Zoology 20
Countries citing papers authored by Lei Yan
This map shows the geographic impact of Lei Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Yan more than expected).
Fields of papers citing papers by Lei Yan
This network shows the impact of papers produced by Lei Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Yan. The network helps show where Lei Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Lei Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 61 | |
| 2 | 2022 | 58 | |
| 3 | 2017 | 35 | |
| 4 | 2023 | 27 | |
| 5 | 2022 | 24 | |
| 6 | 2020 | 23 | |
| 7 | 2023 | 22 | |
| 8 | 2025 | 22 | |
| 9 | 2022 | 19 | |
| 10 | 2022 | 19 | |
| 11 | 2024 | 17 | |
| 12 | 2013 | 14 | |
| 13 | 2023 | 11 | |
| 14 | 2021 | 10 | |
| 15 | 2023 | 9 | |
| 16 | 2024 | 9 | |
| 17 | 2025 | 9 | |
| 18 | 2012 | 8 | |
| 19 | 2014 | 8 | |
| 20 | 2023 | 8 |
About Lei Yan
Lei Yan is a scholar working on Pulmonary and Respiratory Medicine, Complementary and alternative medicine, Oncology, Cardiology and Cardiovascular Medicine and Nephrology, having authored 56 papers that have together received 515 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Breast Cancer Treatment Studies (3 papers), Acute Kidney Injury Research (2 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Wound Healing and Treatments (2 papers), Ferroptosis and cancer prognosis (2 papers) and Fungal Biology and Applications (2 papers). The work is most often cited by research in Drug Discovery (2 citations), Pulmonary and Respiratory Medicine (123 citations), Nephrology (32 citations), Complementary and alternative medicine (28 citations) and Animal Science and Zoology (20 citations). Lei Yan has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Jingjing Wang, Xiang Shi, Zhihua Zheng, Kaiji Sun, Guoyao Wu, Zhenlong Wu, Jia Hong Shi, Ali Raza, Xinyi Zhu and Xuemei Zhang. Their work appears in journals such as International Immunopharmacology, Chinese Journal of Natural Medicines, Heliyon, Frontiers in Immunology and Frontiers in Plant Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.